Active · per the CBE, 28 September 2026
BIOQUBE FACTORY FUND I logo

BIOQUBE FACTORY FUND I

BE0747784678

Rechtspersoon Limited partnership 1 establishment

Barricadenplein 13, 1000 Brussel bioqubeventures.com [email protected]

Behind the company: Bioqube Ventures.

Active for

6 year, 3 months

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

  • Two loss years in a row NBB

    Negative result in 2024 and 2025.

  • Busy address KBO

    18 other companies have their registered office at the same address; threshold 10.

Financials

Financial year 2025

BIOQUBE FACTORY FUND I from Brussel, company number BE0747784678, closed financial year 2025 with a result of € -1.1 million after tax. For that financial year BIOQUBE FACTORY FUND I recorded a gross margin of € -1.3 million and equity of € 67 million. Compared with financial year 2024, the result moved from € -1.8 million to € -1.1 million. The company made a loss. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 12, 2026.

What it is worth Growing

€ 67 million

▲ 16% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -1.1 million

▲ 39 % less loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 10 million

▲ 105% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -11.8 million.

People and assets in 2025

Full-time equivalents

0

Average over the fiscal year, from the social balance sheet.

Debts at end 2025

Bank debt

€ 83,122

▼ 80% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 45,874

▼ 59% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
2022202320242025Change 2024 → 2025
Gross margin € -2,339,432 € -2,367,905 € -2,408,170 € -1,279,479 ▲ € 1.1 million
Profit after taxes € -2,494,057 € -2,374,105 € -1,822,047 € -1,111,932 ▲ € 710,115
Equity € 23,847,619 € 41,893,644 € 57,732,249 € 66,964,106 ▲ 16%
Total debts € 665,434 € 584,037 € 2,137,893 € 1,338,988 ▼ 37%
Cash € 1,965,137 € 4,087,891 € 4,900,690 € 10,049,538 ▲ 105%
Retained profit € -6,506,628 € -8,880,733 € -10,702,780 € -11,814,713 ▼ € 1.1 million
Bank debt € 0 € 0 € 415,840 € 83,122 ▼ 80%
Balance sheet total € 24,513,053 € 42,477,680 € 59,870,143 € 68,303,094 ▲ 14%

Key figures of BIOQUBE FACTORY FUND I, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to BIOQUBE FACTORY FUND I?

What happened at BIOQUBE FACTORY FUND I in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: loss of € 1.1 million. Source: NBB ↗
  • New establishment in Brussel. KBO
  • Start of the company according to the CBE. KBO
  • Bioqube Ventures became a director. NBB

In short

From € 2.5 million loss in 2022 to € 1.1 million loss in 2025.

Paid € 59 in corporate taxes since 2022.

Management

The stake of NICO VANDERVELPEN MANAGEMENT COMPANY, DEBORA DUMONT MANAGEMENT COMPANY comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

BIOQUBE FACTORY FUND I

Behind BIOQUBE FACTORY FUND I is Bioqube Ventures. The shares are held by NICO VANDERVELPEN MANAGEMENT COMPANY (1%) and DEBORA DUMONT MANAGEMENT COMPANY (1%). It owns 100% of Neohla, 100% of Groovy.bio, 60.4% of Temmune Therapeutics, 42.2% of Spica Therapeutics, 26.9% of Commit Biologics Aps and 15.4% of Anavo Therapeutics Inc itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Bioqube Ventures

Manager · represented by Dumont Debora

Also active at: Bioqube Factory Project Company, FLANDERSBIO

since 2020

Participations

Neohla

100%

Commit Biologics Aps

26.9%

Anavo Therapeutics Inc

15.4%

Primmune Therapeutics Inc

15.1%

Enhanc3d Genomics Ltd

12.4%

Tridek-One Therapeutics

10.2%

Establishments

Establishment units

Physical locations of this company

Registered office

Barricadenplein 13

1000 Brussel

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

Technologies

CookieYesElementorFont AwesomeGoogle FontsGoogle Tag ManagerPHPSlickWordPressYoast SEOjQueryjQuery UIlazysizes

Hosting & Email

Email provider

Microsoft 365

Hosting

FASTLY - Fastly, Inc., US

Domain

Domain

bioqubeventures.com

Registered

2016-03-11

Registrar

Ascio Technologies, Inc. Danmark - Filial af Ascio technologies, Inc. USA

Expires

2027-03-11

Website info

HTTPS Ja
Languages EN
Copyright 2026

Features

Webshop Ads

Security

✓ HTTPS
✓ SPF
✓ DMARC

Details

Company number
0747.784.678
VAT number
BE 0747.784.678
Registered office
Barricadenplein 13, 1000 Brussel
Names & denominations
BIOQUBE FACTORY FUND I · BFF I
Enterprise type
Rechtspersoon
Legal form
Limited partnership
Legal situation
Normale toestand
Start date
2 June 2020
Peppol
Active · Active since 24 Jun 2025

Frequently asked questions

What is the address of BIOQUBE FACTORY FUND I?
The registered office of BIOQUBE FACTORY FUND I is located at Barricadenplein 13, 1000 Brussel.
Is BIOQUBE FACTORY FUND I still active?
Yes. According to the CBE (28 September 2026) BIOQUBE FACTORY FUND I is active, legal situation “Normale toestand”, started on 2 June 2020.
Is BIOQUBE FACTORY FUND I registered on Peppol?
Yes, BIOQUBE FACTORY FUND I is registered on the Peppol network with ID 0208:0747784678.
What is the enterprise number of BIOQUBE FACTORY FUND I?
The enterprise number of BIOQUBE FACTORY FUND I is BE0747784678.
When was BIOQUBE FACTORY FUND I founded?
BIOQUBE FACTORY FUND I was founded on 2 June 2020.
Who owns BIOQUBE FACTORY FUND I?
Behind BIOQUBE FACTORY FUND I is Bioqube Ventures. The shares are held by NICO VANDERVELPEN MANAGEMENT COMPANY (1%) and DEBORA DUMONT MANAGEMENT COMPANY (1%). It owns 100% of Neohla, 100% of Groovy.bio, 60.4% of Temmune Therapeutics, 42.2% of Spica Therapeutics, 26.9% of Commit Biologics Aps and 15.4% of Anavo Therapeutics Inc itself.